MedTrace Logo

TFL vs MOSES Holmium Laser in the En-bloc Resection of Bladder Tumors

NCT06373419 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-04-18

No results posted yet for this study

Summary

The goal of this randomized clinical trial is to determine if there is difference in pathological and clinical outcomes between MOSES and TFL in the transurethral laser enucleation of bladder tumors.

The main question it aims to answer is:

Is there a difference in pathological and clinical outcomes between MOSES Holmium and Thulium Fiber Laser (TFL) in the transurethral laser enucleation of bladder tumors?

Participants will randomized to either TFL of MOSES arm for their bladder resection procedure.

Conditions

  • Urolithiasis of Bladder

Interventions

DEVICE

TFL

Participant undergoing bladder tumour resection that has been randomized to this arm.

DEVICE

MOSES holmium laser

Participant undergoing bladder tumour resection that has been randomized to this arm.

Sponsors & Collaborators

  • Thunder Bay Regional Health Research Institute

    lead OTHER

Principal Investigators

  • Ahmed Z Ahmed · Thunder Bay Regional Health Sciences Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-16
Primary Completion
2025-10-31
Completion
2026-10-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06373419 on ClinicalTrials.gov